We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Image: Spatial characterization of immune–tumor interactions and treatment response across SCLC and extended phenotype models (Cristian Barrera et al, npj Precision Oncology (2026). DOI: 10.1038/s41698-025-01225-9)

AI Pathology Tool Predicts Chemotherapy Response in Small Cell Lung Cancer

An AI approach predicts response to platinum chemotherapy in SCLC from routine biopsy slides, enabling faster first-line decisions More...
08 Apr 2026
Image: The cobas c 703 and cobas ISE neo increase testing capacity and automation to enhance lab workflows and patient care (photo courtesy of Roche)

Next Generation Automated Analyzers Increase Throughput for Clinical Chemistry and Electrolyte Testing

Roche has received FDA 510(k) clearance for cobas c703 and cobas ISE neo, next-generation units that enhance laboratory efficiency and capability. More...
08 Apr 2026
Image: The collaboration pairs Pillar’s oncoReveal kitted NGS panels with CellCarta’s global laboratory network and biomarker expertise (photo courtesy of Pillar Biosciences)

Global Partnership Aims to Streamline NGS Tumor Profiling in Oncology Trials

CellCarta and Pillar Biosciences announced a global, multi-year strategic partnership to broaden access to operationally streamlined NGS tumor profiling for biopharma sponsors and clinical research partners worldwide. More...
07 Apr 2026
Image: The method that profiles DNA methylation in cell-free DNA from a single blood sample to detect disease signals system-wide (photo courtesy of Shutterstock)

cfDNA Methylation Assay Enables Multi-Disease Detection from Single Blood Sample

A new cfDNA methylation assay screens for multiple cancers and organ diseases from one blood draw with tissue-of-origin mapping. More...
07 Apr 2026
Image: FINDER is the first molecular point-of-care platform with both FDA 510(k) clearance and CLIA waiver that combines molecular testing with chemistry, coagulation, and immunoassay capabilities on a single multifunctional system (photo courtesy of Baebies)

Rapid Point-of-Care RT-PCR Test Differentiates Influenza A/B and SARS-CoV-2 in Minutes

Baebies has received FDA 510(k) clearance and CLIA waiver for the FINDER Flu A&B/SARS-CoV-2 Test. More...
07 Apr 2026
Image: Higher midlife vitamin D levels are linked to lower tau accumulation later, though the association does not establish causation (photo courtesy of Shutterstock)

Study Links Midlife Vitamin D to Lower Tau in Alzheimer's

A new study shows that higher midlife vitamin D levels are associated with lower tau accumulation years late More...
07 Apr 2026
Image: Through neoadjuvant therapy combining chemotherapy with immune checkpoint inhibitors (ICI) for 46 LAGC patients and single-cell transcriptome sequencing, researchers found that tumor cells in the treatment-sensitive group specifically upregulated MHC-II (tumor-specific major histocompatibility complex class II, tsMHC-II) molecules (photo courtesy of Science China Press)

Tumor-Specific Biomarker Predicts Neoadjuvant Immunotherapy Response in Gastric Cancer

A new test using routine immunohistochemistry detects tumor-specific biomarker that predicts neoadjuvant immunotherapy response in gastric cancer. More...
07 Apr 2026
Visit expo >
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Repetitive Pipette
VWR® Stepper Pro
New
Chromogenic Culture System
InTray™ COLOREX™ ECC

In Other News

Copyright © 2000 - 2026 Globetech Media.
All rights reserved.